PHARMA - Relationships

Relationships Table

Entities - Color - Target Drug Disease Lo Med Hi
Word 1
Word 1 Count
CAT1
CAT2
Word 2
Word 2 Count
Co-occurrence
Occurence-Centile
Correlation
Overlap-Metric
G-Metric
Tubulin Beta-1 Chain 3 Target Target Inosine-5'-Monophosphate Dehydrogenase 261 1 0.04 -0.81 0.33 0.76
CXCL11 526 Target Target CXCL4/PF4 9 3 0.04 -0.81 0.33 0.76
Cancer 1,053,491 Disease Target CHK1 2,044 681 0.01 -0.82 0.33 0.60
Cancer 1,053,491 Disease Target AKT2 873 284 0.01 -0.82 0.33 0.59
CCL2 3,560 Target Target CXCL10/IP-10 114 37 0.06 -0.82 0.32 0.75
CXCL10/IP-10 114 Target Target CXCL9 1,016 37 0.11 -0.81 0.32 0.81
Obesity 138,233 Disease Target Adiponectin 11,994 3,886 0.10 -0.81 0.32 0.72
BMP-4 1,255 Target Target BMP-2 3,889 399 0.18 -0.78 0.32 0.83
Infection 766,637 Disease Target CRG-2 41 13 0.00 -0.83 0.32 0.57
Ovarian Cancer 33,996 Disease Target Kallikrein-8 19 6 0.01 -0.83 0.32 0.64
CD4 112,219 Target Target CD154 1,512 477 0.04 -0.83 0.32 0.67
Cancer 1,053,491 Disease Target Glutathione S-Transferase Theta-1 70 22 0.00 -0.83 0.31 0.57
EPHB2 385 Target Target EPHB1 137 43 0.19 -0.78 0.31 0.86
Cancer 1,053,491 Disease Target Epiregulin 291 91 0.01 -0.83 0.31 0.58
BD2 76 Target Target BD3 32 10 0.20 -0.77 0.31 0.88
Arixtra (Fondaparinux Sodium)- FDA 16 Drug Target Bivalirudin 891 5 0.04 -0.83 0.31 0.75
CCL7 274 Target Target CCL8 197 60 0.26 -0.74 0.30 0.90
BMP-7 1,112 Target Target BMP-2 3,889 338 0.16 -0.80 0.30 0.82
Niemann Pick Disease 1,234 Disease Target Sphingomyelinase 3,060 369 0.19 -0.79 0.30 0.84
CCN5 57 Target Target CYR61 539 17 0.10 -0.82 0.30 0.81
Cancer 1,053,491 Disease Target BRK 236 70 0.00 -0.84 0.30 0.57
Epidermal Growth Factor Receptor 24,772 Target Target Epigen 27 8 0.01 -0.84 0.30 0.65
Epigen 27 Target Target Epiregulin 291 8 0.09 -0.83 0.30 0.81
Cancer 1,053,491 Disease Target Urokinase-Type Plasminogen Activator 3,939 1,166 0.02 -0.84 0.30 0.60
Epidermal Growth Factor Receptor 24,772 Target Target beta-Cellulin 17 5 0.01 -0.84 0.29 0.65
Endostatin 1,599 Target Target Angiostatin K1-3 17 5 0.03 -0.84 0.29 0.73
Cancer 1,053,491 Disease Target CAPG 85 25 0.00 -0.84 0.29 0.57
Cancer 1,053,491 Disease Target beta-Cellulin 17 5 0.00 -0.84 0.29 0.56
Diabetes 332,602 Disease Target Adiponectin 11,994 3,433 0.05 -0.84 0.29 0.66
Carcinoma 433,099 Disease Target AP2M1 7 2 0.00 -0.85 0.29 0.57
Cancer 1,053,491 Disease Target AP2M1 7 2 0.00 -0.85 0.29 0.56
Cancer 1,053,491 Disease Target EPHB4 329 94 0.01 -0.85 0.29 0.58
Cancer 1,053,491 Disease Target CXCL14/BRAK 7 2 0.00 -0.85 0.29 0.56
CD31/PECAM1 7 Target Target CD34 24,598 2 0.00 -0.85 0.29 0.64
Abciximab (ReoPro)- FDA 7 Drug Target Eptifibatide 772 2 0.03 -0.84 0.29 0.73
Leukemia 162,805 Disease Target Cardiotrophin-1 351 100 0.01 -0.85 0.28 0.63
AACT 109 Target Target Alpha-1 AntiChymotrypsin 1,460 31 0.08 -0.84 0.28 0.78
Cancer 1,053,491 Disease Target CCN5 57 16 0.00 -0.85 0.28 0.56
Cancer 1,053,491 Disease Target Ret Proto-Oncogene 1,005 281 0.01 -0.85 0.28 0.58
Cancer 1,053,491 Disease Target Hypoxia-Inducible Factor 1-Alpha 923 257 0.01 -0.85 0.28 0.58
Aldosterone Receptor 528 Target Target Renin 43,456 147 0.03 -0.85 0.28 0.68
Des (1-3) IGF-I 191 Target Target Des (1-6) IGF-II 18 5 0.09 -0.84 0.28 0.81
Angiotensin Converting Enzyme 31,674 Target Target Aldosterone Receptor 528 146 0.04 -0.85 0.28 0.69
Cancer 1,053,491 Disease Target Cytokeratin 8 587 162 0.01 -0.85 0.28 0.58
Epidermal Growth Factor Receptor 24,772 Target Target Epiregulin 291 80 0.03 -0.85 0.27 0.69
Cancer 1,053,491 Disease Target ERBB4 994 273 0.01 -0.85 0.27 0.58
Diabetes 332,602 Disease Target ADSF 11 3 0.00 -0.85 0.27 0.58
ADSF 11 Target Target Adiponectin 11,994 3 0.01 -0.85 0.27 0.66
Cholesterol 182,390 Disease Target APOC1 126 34 0.01 -0.85 0.27 0.61
CD4 112,219 Target Target 4-1BB Ligand 135 36 0.01 -0.86 0.27 0.63